Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Nadhir medical AB
AB
Active
Org 5590564349
Lidaleden 716, 603 81
Norrköping
Hospital activities
· NACE 8610
Est. 2016
1 employees
Watchlist
Share
Sweden
/
Companies
/
Hospital activities
/
Nadhir medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
0M
2021
1M
2022
3M
2023
3M
2024
3M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
0M
2021
1M
2022
2M
2023
2M
2024
2M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
673
2 812
2 709
2 641
Staff expenses
—
−16
−903
−933
−624
EBITDA
−6
705
1 812
1 908
1 787
Depreciation & amort.
−4
−3
—
—
—
EBIT
−10
702
1 812
1 908
1 787
Net financials
—
—
−0
−2
−10
Profit before tax
−10
702
1 372
1 435
1 337
Tax
−0
−139
−283
−299
−281
Net profit
−10
563
1 090
1 137
1 056
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
229
1 052
2 804
4 226
5 138
Equity
216
779
1 169
1 996
2 742
Long-term debt
7
0
—
—
—
Short-term debt
6
272
1 195
1 320
1 046
Total debt
13
272
1 195
1 320
1 046
Financial ratios
5-year trend
EBITDA margin
67.7%
This company
15.8%
Market median
+328% vs market
2021
2025
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
2021
2025
Return on equity
38.5%
This company
18.4%
Market median
+109% vs market
2021
2025
Net profit margin
40.0%
This company
8.1%
Market median
+394% vs market
2021
2025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
2021
2025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
View
PDF
More on Nadhir medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network